Trinity Biotech plc Stock

Equities

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 01:30:00 2024-07-03 pm EDT 5-day change 1st Jan Change
2.14 USD +5.42% Intraday chart for Trinity Biotech plc +2.88% -0.23%
Sales 2024 * 62.7M Sales 2025 * 71M Capitalization 20.26M
Net income 2024 * -19M Net income 2025 * -9M EV / Sales 2024 * 0.32 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.29 x
P/E ratio 2024 *
-0.99 x
P/E ratio 2025 *
-2.06 x
Employees 380
Yield 2024 *
-
Yield 2025 *
-
Free-Float 89.35%
More Fundamentals * Assessed data
Dynamic Chart
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading MT
Trinity Biotech plc to Begin European Pre-Pivotal Trial to Optimize Its Cgm Sensor CI
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading MT
Gamida Cell Names Rory Nealon as Chief Financial Officer CI
Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading MT
European Equities Traded in the US as American Depositary Receipts Sharply Lower in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading MT
More news
1 day+5.42%
1 week+2.88%
Current month+0.47%
1 month+29.70%
3 months+9.18%
6 months-2.62%
Current year-0.23%
More quotes
1 week
1.98
Extreme 1.98
2.29
1 month
1.74
Extreme 1.74
3.55
Current year
1.49
Extreme 1.49
3.55
1 year
1.49
Extreme 1.49
5.50
3 years
1.49
Extreme 1.49
15.25
5 years
1.49
Extreme 1.49
34.11
10 years
1.49
Extreme 1.49
120.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 43 20-11-16
Founder 68 92-05-31
Chief Tech/Sci/R&D Officer 40 15-08-31
Members of the board TitleAgeSince
Founder 68 92-05-31
Director/Board Member 65 95-09-30
Director/Board Member 66 22-10-25
More insiders
Date Price Change Volume
24-07-03 2.14 +5.42% 19 224
24-07-02 2.03 -7.73% 39,889
24-07-01 2.2 +3.29% 15,827
24-06-28 2.13 +2.40% 36,215
24-06-27 2.08 +0.97% 36,653

Delayed Quote Nasdaq, July 03, 2024 at 01:30 pm EDT

More quotes
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.
More about the company